no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
Beyond 30 years of universal anti-hepatitis B vaccination in Italy: Success and areas of improvement
|
Romanò, Luisa |
|
|
40 |
38 |
p. 5542-5543 |
article |
2 |
Bivalent hemagglutinin and neuraminidase influenza replicon particle vaccines protect pigs against influenza a virus without causing vaccine associated enhanced respiratory disease
|
Wymore Brand, Meghan |
|
|
40 |
38 |
p. 5569-5578 |
article |
3 |
Considerations for the chemistry, manufacturing and Controls (CMC) - quality package for COVID-19 vaccines- interim lessons learnt by the European medicines Agency (EMA)
|
Shivji, Ragini |
|
|
40 |
38 |
p. 5539-5541 |
article |
4 |
Development of a cell line-based in vitro assay for assessment of Diphtheria, Tetanus and acellular Pertussis (DTaP)-induced inflammasome activation
|
Vandebriel, Rob J. |
|
|
40 |
38 |
p. 5601-5607 |
article |
5 |
Editorial Board/Aims and Scope
|
|
|
|
40 |
38 |
p. IFC |
article |
6 |
Evaluation of five circulating strains of variant infectious bursal disease virus (varIBDV) for their immunogenicity as broiler breeder vaccines and protective efficacy in neonatal broiler chicks
|
Kurukulasuriya, Shanika |
|
|
40 |
38 |
p. 5608-5614 |
article |
7 |
Humoral response to different SARS-CoV-2 vaccines in orthotopic liver transplant recipients
|
Toapanta-Yanchapaxi, Liz |
|
|
40 |
38 |
p. 5621-5630 |
article |
8 |
Improving management of vaccine supply chains: A multi-methods evaluation of vSTEP in Zambia
|
Linnander, Erika |
|
|
40 |
38 |
p. 5579-5584 |
article |
9 |
Kinetics of anti-SARS-CoV-2 antibody titer in healthy adults up to 6 months after BNT162b2 vaccination measured by two immunoassays: A prospective cohort study in Japan
|
Matsuura, Tomoka |
|
|
40 |
38 |
p. 5631-5640 |
article |
10 |
Parents’ views on the acceptability of a COVID-19 vaccine for their children: A cross-sectional study in Abu Dhabi-United Arab Emirates
|
AlKetbi, Latifa Mohammad Baynouna |
|
|
40 |
38 |
p. 5562-5568 |
article |
11 |
Phenotypic and genetic characterization of a next generation live-attenuated yellow fever vaccine candidate
|
Esson, Raphael |
|
|
40 |
38 |
p. 5641-5650 |
article |
12 |
Stamping the vaccine passport? Public support for lifting COVID-19 related restrictions for vaccinated citizens in France, Germany, and Sweden
|
Stoeckel, Florian |
|
|
40 |
38 |
p. 5615-5620 |
article |
13 |
Suitable but requiring support: How the midwifery model of care offers opportunities to counsel the vaccine hesitant pregnant population
|
Pringle, Wendy |
|
|
40 |
38 |
p. 5594-5600 |
article |
14 |
Thrombosis with thrombocytopenia after AZD1222 (ChAdOx1 nCov-19) vaccination: Case characteristics and associations
|
Laffan, Michael A |
|
|
40 |
38 |
p. 5585-5593 |
article |
15 |
Travel time to health facilities in Papua New Guinea: Implications for coverage and equity in child vaccinations
|
Ishida, Marie |
|
|
40 |
38 |
p. 5556-5561 |
article |
16 |
Use of protective antigen of Bacillus anthracis as a model recombinant antigen to evaluate toll-like receptors 2, 3, 4, 7 and 9 agonists in mice using established functional antibody assays, antigen-specific antibody assays and cellular assays
|
Inglefield, Jon |
|
|
40 |
38 |
p. 5544-5555 |
article |